GSK plc Noncurrent Investments Other Than Investments Accounted For Using Equity Method
GSK plc (GSK) had Noncurrent Investments Other Than Investments Accounted For Using Equity Method of GBP 1.04 billion as of 2025-12-31, per its 20-F filed 2026-03-06.
Financial Statements › Notes
ifrs-full:NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod · last filed 2026-03-06
- 2025-12-31: Noncurrent Investments Other Than Investments Accounted For Using Equity Method 1.04B GBP.
- 2024-12-31: Noncurrent Investments Other Than Investments Accounted For Using Equity Method 1.10B GBP.
- 2023-12-31: Noncurrent Investments Other Than Investments Accounted For Using Equity Method 1.14B GBP.
- 2022-12-31: Noncurrent Investments Other Than Investments Accounted For Using Equity Method 1.47B GBP.
| Period end | Noncurrent Investments Other Than Investments Accounted For Using Equity Method |
|---|---|
| 2025-12-31 | 1.04B GBP 20-F · filed 2026-03-06 |
| 2024-12-31 | 1.10B GBP 20-F · filed 2026-03-06 |
| 2023-12-31 | 1.14B GBP 20-F · filed 2025-03-03 |
| 2022-12-31 | 1.47B GBP 20-F · filed 2024-03-05 |
| 2021-12-31 | 2.13B GBP 20-F · filed 2023-03-10 |